Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

1U93

Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide Analog EQDKW-[Dap]-S (cyclic)

Summary for 1U93
Entry DOI10.2210/pdb1u93/pdb
Related1U8H 1U8I 1U8J 1U8K 1U8L 1U8M 1U8N 1U8O 1U8P 1U8Q 1U91 1U92 1U95 2F5A 2F5B
DescriptorANTIBODY 2F5 (LIGHT CHAIN), ANTIBODY 2F5 (HEAVY CHAIN), GP41 PEPTIDE ANALOG, ... (4 entities in total)
Functional Keywordsfab complex, hiv-1 neutralization, gp41 peptide, immune system
Biological sourceHomo sapiens (human)
More
Total number of polymer chains3
Total formula weight49197.17
Authors
Bryson, S.,Julien, J.-P.,Hynes, R.C.,Pai, E.F. (deposition date: 2004-08-09, release date: 2004-10-05, Last modification date: 2024-10-23)
Primary citationBryson, S.,Julien, J.-P.,Hynes, R.C.,Pai, E.F.
Crystallographic definition of the epitope promiscuity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5: vaccine design implications
J.Virol., 83:11862-11875, 2009
Cited by
PubMed Abstract: The quest to create a human immunodeficiency virus type 1 (HIV-1) vaccine capable of eliciting broadly neutralizing antibodies against Env has been challenging. Among other problems, one difficulty in creating a potent immunogen resides in the substantial overall sequence variability of the HIV envelope protein. The membrane-proximal region (MPER) of gp41 is a particularly conserved tryptophan-rich region spanning residues 659 to 683, which is recognized by three broadly neutralizing monoclonal antibodies (bnMAbs), 2F5, Z13, and 4E10. In this study, we first describe the variability of residues in the gp41 MPER and report on the invariant nature of 15 out of 25 amino acids comprising this region. Subsequently, we evaluate the ability of the bnMAb 2F5 to recognize 31 varying sequences of the gp41 MPER at a molecular level. In 19 cases, resulting crystal structures show the various MPER peptides bound to the 2F5 Fab'. A variety of amino acid substitutions outside the 664DKW666 core epitope are tolerated. However, changes at the 664DKW666 motif itself are restricted to those residues that preserve the aspartate's negative charge, the hydrophobic alkyl-pi stacking arrangement between the beta-turn lysine and tryptophan, and the positive charge of the former. We also characterize a possible molecular mechanism of 2F5 escape by sequence variability at position 667, which is often observed in HIV-1 clade C isolates. Based on our results, we propose a somewhat more flexible molecular model of epitope recognition by bnMAb 2F5, which could guide future attempts at designing small-molecule MPER-like vaccines capable of eliciting 2F5-like antibodies.
PubMed: 19740978
DOI: 10.1128/JVI.01604-09
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.37 Å)
Structure validation

227344

건을2024-11-13부터공개중

PDB statisticsPDBj update infoContact PDBjnumon